Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

8i Acquisition 2 Corp. (LAX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.870.00 (0.00%)
At close: 09:30AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close9.87
Open9.87
Bid3.95 x 2200
Ask9.89 x 1000
Day's Range9.87 - 9.87
52 Week Range9.65 - 10.40
Volume51
Avg. Volume33,620
Market Cap109.295M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.01
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for LAX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • 8i Acquisition 2 Corp.
    Daily – Vickers Top Insider Picks for 04/07/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • GlobeNewswire

    8i Acquisition 2 Corp. and EUDA Health Limited Announce Amendment to Share Purchase Agreement

    Singapore, June 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the “Company” or “LAX”) (NASDAQ: LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited (“EUDA Health”), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare, today announced an amendment to the Share Purchase Agreement (the “SPA Amendment”) to, among oth

  • GlobeNewswire

    8i Acquisition 2 Corp. and EUDA Health Limited Announce Extension of Due Diligence Review Period

    Singapore, May 31, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the “Company” or “LAX”) (NASDAQ: LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited, a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare, today announced an amendment to the SPA (the “SPA Amendment”) to extend the time for LAX to complete its financia

  • GlobeNewswire

    8i Acquisition 2 Corp. to Combine with EUDA Health Limited to Bring a Leading Digital Health Platform Servicing Southeast Asia to the Public Market

    EUDA Health is disrupting the multi-trillion-dollar Southeast Asia healthcare industry with its proprietary unified AI platform that makes healthcare affordable, accessible, and personalized across Southeast Asia— one of the fastest growing healthcare technology markets in the world Pro forma enterprise value of the combined company is expected to be approximately $580 million with cash on hand of approximately $90 million, assuming no redemptions Singapore, April 12, 2022 (GLOBE NEWSWIRE) -- EU

Advertisement
Advertisement